World Health Organisation (WHO) continues successful collaboration with Paul-Ehrlich-Institut

Recommendation
27/28 May 2025
Vienna, Austria
Regulatory Requirements and Practical Implementation
After eight years of successful collaboration as a "WHO Collaborating Centre for Quality Assurance of Blood Products and in vitro Diagnostic Devices" the World Health Organization (WHO) has confirmed that it will continue working with the Paul-Ehrlich-Institut (PEI) for another four years. The President of the Paul-Ehrlich Institut, Professor Klaus Cichutek, is proud that the institute is being recognised in this way: "PEI has achieved this thanks to its in-depth expertise in a wide range of areas connected with regulatory affairs and scientific research as well as its sustained and reliable support of the WHO’s activities". During his visit to the PEI on 1 July 2013, Daniel Bahr, the German Federal Minister of Health, confirmed that "The quality of the PEI's work is very highly appreciated by the WHO."
More details can be found in the PEI's press release entitled "World Health Organization (WHO) continues successful collaboration with Paul-Ehrlich-Institut".
Related GMP News
14.05.2025EMA Proposes Revisions to GMP Guideline for ATMPs
07.05.2025FDA Initiates Transition to Non-Animal Testing Methods for Monoclonal Antibodies
16.04.2025FDA Warning Letter: Unauthorised Distribution of Fecal Microbiota Transplant Products
16.04.2025Development of a Risk-based Quality System for CMC R&D Laboratories in Drug Development
03.04.2025European Pharmacopoeia Commission Adopts First General Texts on mRNA Vaccines